Natera, Inc.·4

Apr 29, 9:45 PM ET

Brophy Michael Burkes 4

4 · Natera, Inc. · Filed Apr 29, 2026

Research Summary

AI-generated summary of this filing

Updated

Natera (NTRA) CFO Michael Brophy Sells Shares

What Happened

  • Michael Brophy (CFO) disposed of a total of 5,063 Natera (NTRA) shares in open-market sales on April 27 and April 29, 2026, generating aggregate proceeds of about $1,001,646.
    • 2026-04-27: 771 shares @ $203.75 = $157,091 (sale)
    • 2026-04-27: 1,222 shares @ $204.39 = $249,765 (sale)
    • 2026-04-29: 300 shares @ $190.12 = $57,035 (sale)
    • 2026-04-29: 500 shares @ $192.13 = $96,064 (sale)
    • 2026-04-29: 1,000 shares @ $193.78 = $193,779 (sale)
    • 2026-04-29: 1,070 shares @ $194.82 = $208,460 (sale)
    • 2026-04-29: 200 shares @ $197.26 = $39,452 (sale)
  • These are sales (not purchases) and are typically viewed as routine transactions rather than a direct bullish signal.

Key Details

  • Transaction dates: April 27, 2026 and April 29, 2026. Prices ranged from about $190.08 to $204.39 across the trades (several reported as weighted-average prices with narrower ranges noted).
  • Shares owned after the transactions: Not specified in the information provided.
  • Reported reasons/footnotes:
    • Some sales were to satisfy tax withholding related to RSU vesting (footnotes indicate RSUs granted Jan 26, 2024 and Jan 27, 2023).
    • Other sales were effected pursuant to a Rule 10b5‑1 trading plan adopted June 9, 2025 (amended Sept 5, 2025).
    • Several prices are reported as weighted averages with specific per-share ranges disclosed in the filing (holder will provide breakdown on request).
  • Filing timeliness: Form 4 was filed April 29, 2026 for transactions on April 27 and April 29 — appears to be a timely filing.

Context

  • Sales to cover tax withholding for vested RSUs and trades executed under a 10b5‑1 plan are common and generally considered routine administrative transactions.
  • No purchases, option exercises, or gifts were reported in this filing.

Insider Transaction Report

Form 4
Period: 2026-04-27
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
Transactions
  • Sale

    Common Stock

    [F1]
    2026-04-27$203.75/sh771$157,09162,583 total
  • Sale

    Common Stock

    [F2]
    2026-04-27$204.39/sh1,222$249,76561,361 total
  • Sale

    Common Stock

    [F3][F4]
    2026-04-29$190.12/sh300$57,03561,061 total
  • Sale

    Common Stock

    [F3][F5]
    2026-04-29$192.13/sh500$96,06460,561 total
  • Sale

    Common Stock

    [F3][F6]
    2026-04-29$193.78/sh1,000$193,77959,561 total
  • Sale

    Common Stock

    [F3][F7]
    2026-04-29$194.82/sh1,070$208,46058,491 total
  • Sale

    Common Stock

    [F3]
    2026-04-29$197.26/sh200$39,45258,291 total
Footnotes (7)
  • [F1]The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units ("RSUs") and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 26, 2024.
  • [F2]The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreements granted on January 27, 2023.
  • [F3]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2025, as amended on September 5, 2025.
  • [F4]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.08 to $190.19 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.83 to $192.51 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F6]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.26 to $194.12 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F7]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.45 to $195.11 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Tami Chen, Attorney-in-Fact|2026-04-29

Documents

1 file
  • 4
    form4-04292026_090402.xmlPrimary